Skip to main content
OpenTrials

Clinical trial condition

Huntington's Disease

Explore clinical trials studying Huntington's Disease. Study availability and eligibility vary by location and protocol.

68 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Huntington's Disease trial results

Completed

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

NCT05107128

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Sage Investigational Site Little Rock, Arkansas, United States
  • Sage Investigational Site La Jolla, California, United States
  • Sage Investigational Site Los Angeles, California, United States
  • Sage Investigational Site Sacramento, California, United States
View all 49 locations
View Trial Details
Completed

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

NCT03664804

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • CenExel Rocky Mountain Clinical Research, LLC Englewood, Colorado, United States
  • Georgetown University; Research Division, Psychiatry Washington D.C., District of Columbia, United States
  • Hereditary Neurological Disease Centre (HNDC) Wichita, Kansas, United States
  • John Hopkins University School of Medicine Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease

NCT00665223

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • LKH -Univ. Klinikum Graz, Universitaetsklinik fur Psychiatrie Graz Graz, Styria, Austria
  • Innsbruck Medical University, Anichstraße 35 Innsbruck, Tyrol, Austria
  • University Hospital Gasthuisberg Leuven, Flemish Brabant, Belgium
  • CHU Roger Salengro Lille, Hauts-de-France, France
View all 31 locations
View Trial Details
Completed

Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease

NCT02507284

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • UCLA, Neurology Clinic Los Angeles, California, United States
  • UC Davis Medical Center, Department of Neurology, CTSC Clinical Research Center Sacramento, California, United States
  • University of Colorado Hospital Translational Research Center Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States

NCT03628235

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Rocky Mountain Movement Disorder, P.C. Englewood, Colorado, United States
  • University of South Florida Tampa, Florida, United States
  • Hereditary Neurological Disease Centre, Inc. Wichita, Kansas, United States
View Trial Details
Completed

A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi

NCT02481674

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado - Denver Aurora, Colorado, United States
View all 32 locations
View Trial Details

Related conditions